Commodity Stocks 2026: GSG, LPG, PXT.TO, USO Analyzed

The commodity trade is not subtle this year. The iShares S&P GSCI Commodity-Indexed Trust (GSG) has returned 47.0% over the past twelve months. The United States Oil Fund (USO) is up 72.4%. Teucrium Wheat Fund (WEAT) has gained 32.1%. These are not rounding errors; they are some of the strongest momentum readings across the entire ACCE universe, and they are happening while equity investors remain fixated on AI infrastructure and megacap tech.

The question worth asking in August 2026 is whether this is a momentum trade running on fumes, or whether the underlying fundamentals in energy and materials actually support the move.

What the Broad Commodity Funds Are Telling You

GSG carries an ACCE score of 99/100, with Value at 100 and Momentum at 97. That combination, deep value and strong price action together, is unusual. Momentum alone can be a crowded trade. Value alone can be a value trap. Both at once suggests the market is still in the process of repricing something, not finishing it.

USO scores 97/100 on Momentum alone. The 72.4% one-year return reflects a genuine oil price move, not a leveraged product distortion. WEAT at 97/100 and up 32.1% tells a similar story in agricultural commodities, where supply constraints from weather and geopolitics have been persistent rather than episodic.

None of these funds pay dividends. The return is pure price appreciation. That matters because it means the buyers are not yield-seekers; they are making a directional call on commodity prices.

The Equity Angle: Where Fundamentals Are Exceptional

Broad commodity funds capture the macro direction. The more interesting opportunity, from an equity research standpoint, is in the individual companies where commodity prices are flowing directly into earnings.

Dorian LPG (LPG) is the clearest example in the current data. Revenue grew 124.0% year over year. Earnings grew 1,263.5%. Net margin sits at 55.6%. ROE is 28.3%. The stock yields 6.8% in dividends on top of that. At a trailing P/E of 6.5 and a forward P/E of 6.1, the market is pricing this as a cyclical that will mean-revert hard. The six-model fair value of $57.03 sits 14.6% above the current price of $49.78, and the ACCE score is 96/100 with perfect scores on Growth (100) and near-perfect on Quality (96) and Momentum (97). The analyst consensus target of $51.80 is more conservative than the fair value model, which itself suggests analysts are discounting the cycle.

The bear case on LPG is straightforward: LPG shipping rates are notoriously volatile, and a margin of 55.6% will not persist indefinitely. The bull case is that the stock is priced as though the cycle has already turned, when the earnings data says it has not.

Parex Resources (PXT.TO) is the other standout. This Canadian-listed energy producer trades at a trailing P/E of 3.4, a number that would look like a data error if the fundamentals did not support it. Revenue grew 86.7% year over year. Earnings grew 822.0%. Net margin is 55.0%. ROE is 27.0%. FCF yield is 8.5%. The six-model fair value of $37.81 represents a 35.6% premium to the current price of $27.88, and the ACCE score is 98/100, with perfect scores on Growth (100), Quality (100), and near-perfect on Value (96) and Momentum (97).

Parex operates primarily in Colombia, which introduces political and operational risk that a Canadian or US-listed producer would not carry. That risk premium is real. But a 3.4x trailing P/E with a 3.9% dividend yield and an 8.5% FCF yield is a significant discount even after accounting for it. The analyst target of $31.08 implies 11.5% upside from current levels, well below what the fair value model suggests.

Why Commodities Are Outperforming in 2026

Three forces are converging. First, the energy transition is capital-intensive and slower than projected, which means conventional energy demand has not collapsed on the timeline the market priced in 2021 and 2022. Second, agricultural supply has been disrupted by weather patterns that are not resolving quickly. Third, the dollar has weakened enough to make dollar-denominated commodities cheaper for non-US buyers, supporting demand.

None of these are permanent conditions. Commodity cycles turn, and they turn faster than equity analysts expect. The relevant question is not whether the cycle will end, but whether current prices already reflect that ending.

The GSG data suggests they do not. A Value score of 100 on a fund that has already returned 47% in a year means the underlying commodity basket is still cheap relative to historical norms, not expensive.

The Biotech Momentum Comparison

For context, the ARK Genomic Revolution ETF (ARKG) has returned 92.4% over the past year, and the Direxion Daily S&P Biotech Bull 3X (LABU) is up 320.7%. The SPDR S&P Biotech ETF (XBI) has gained 79.8%. Biotech momentum is real and running hot.

The difference between biotech momentum and commodity momentum is the underlying driver. Biotech is pricing in FDA approvals, clinical trial results, and M&A. Commodities are pricing in physical supply and demand. The latter is slower to change and, historically, more persistent once established.

What to Watch

The commodity trade has three natural pressure points heading into the final quarter of 2026. OPEC production decisions will affect oil directly and LPG shipping indirectly. Northern hemisphere harvest data will determine whether the wheat move has legs into 2027. And any meaningful dollar strengthening would compress commodity prices in local currency terms, reducing demand from price-sensitive buyers.

For equity investors, the individual names, LPG and PXT.TO specifically, offer something the ETFs do not: operating leverage, dividends, and buyback capacity that can sustain returns even if commodity prices plateau. At current valuations, both stocks are pricing in a significant deterioration that the most recent earnings data does not support.

The commodity cycle is not a consensus trade. That is exactly what makes it worth watching closely through year-end.